3-Amino-4-methoxy-N-(5-chloropyridin-2-yl)benzofuran-2-carboxamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并呋喃
• 英文名称: 3-Amino-4-methoxy-N-(5-chloropyridin-2-yl)benzofuran-2-carboxamide
• 英文别名: 3-amino-N-(5-chloropyridin-2-yl)-4-methoxy-1-benzofuran-2-carboxamide
• 化学式: C₁₅H₁₂ClN₃O₃
• 分子量: 317.732
• InChiKey: ZTGREHDLRONFFR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  22
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  90.4
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  N-(5-chloropyridin-2-yl)-2-hydroxyacetamide 、 2-甲氧基-6-硝基苯甲腈 在 potassium carbonate 作用下， 以 N,N-二甲基乙酰胺 为溶剂， 生成 3-Amino-4-methoxy-N-(5-chloropyridin-2-yl)benzofuran-2-carboxamide
  参考文献：
  名称：

  EP1666478

  摘要：

  公开号：

文献信息

• Benzofuran derivative
  申请人：Kawaguchi Takayuki

  公开号：US20050282808A1

  公开（公告）日：2005-12-22

  The present invention provides a benzofuran derivative of the formula [1]: wherein x is a group of the formula: —N═ or —CH═; Y is an optionally substituted amino group, an optionally substituted cycloalkyl group or an optionally substituted saturated heterocyclic group; A is a single bond, a carbon chain optionally having a double bond within or at the end(s) of the chain, or an oxygen atom; R 1 is a hydrogen atom or a halogen atom; Ring B is an optionally substituted benzene ring; and R 3 is a hydrogen atom, or a pharmaceutically acceptable salt thereof, which is useful as a medicament, especially as an activated blood coagulation factor X inhibitor.

  本发明提供了一种苯并呋喃衍生物，其化学式为[1]：其中x是公式：—N═或—CH═的基团；Y是可选取的取代氨基、可选取的取代环烷基或可选取的饱和杂环基团；A是单键、可选取的具有双键或位于链的末端的碳链或氧原子；R1是氢原子或卤素原子；环B是可选取的取代苯环；R3是氢原子或其药学上可接受的盐，该化合物作为药物特别是激活的血凝血因子X抑制剂。
• Carbamoyl-type benzofuran derivatives
  申请人：Kawaguchi Takayuki

  公开号：US20060247273A1

  公开（公告）日：2006-11-02

  The present invention provides a carbamoyl-type benzofuran derivative of the formula [1]: wherein Ring Z is a group of the formula: etc.; A is a single bond, and the like; Y is a cycloalkanediyl group, etc.; R 4 and R 5 are the same or different and each is an optionally substituted lower alkyl group, etc.; R 1 is a halogen atom, etc.; Ring B of the formula: is an optionally substituted benzene ring; and R 3 is a hydrogen atom. etc., or a pharmaceutically acceptable salt thereof, which is useful as an FXa inhibitor.

  本发明提供了一种公式[1]的氨基甲酰基苯并呋喃衍生物： 其中，环Z是公式等的一组；A是单键等；Y是环烷基二基等；R4和R5相同或不同，每个是可选取的低取代基等；R1是卤素原子等；环B是可选取的苯环；R3是氢原子等；或其药学上可接受的盐，作为FXa抑制剂具有用处。
• Benzofuran Derivatives
  申请人：Kawaguchi Takayuki

  公开号：US20090209511A1

  公开（公告）日：2009-08-20

  The present invention provides a benzofuran derivative of the formula [1]: wherein x is a group of the formula: —N═ or —CH═; Y is an optionally substituted amino group, an optionally substituted cycloalkyl group or an optionally substituted saturated heterocyclic group; A is a single bond, a carbon chain optionally having a double bond within or at the end(s) of the chain, or an oxygen atom; R 1 is a hydrogen atom or a halogen atom; Ring B is an optionally substituted benzene ring; and R 3 is a hydrogen atom, or a pharmaceutically acceptable salt thereof, which is useful as a medicament, especially as an activated blood coagulation factor X inhibitor.

  本发明提供了式[1]的苯并呋喃衍生物：其中x是式：—N═或—CH═的基团；Y是可选取代的氨基基团、可选取代的环烷基团或可选取代的饱和杂环基团；A是单键、具有双键的碳链（可在链的内部或端部）或氧原子；R1是氢原子或卤原子；环B是可选取代的苯环；R3是氢原子或其药学上可接受的盐，其作为药物特别是作为激活的血凝因子X抑制剂有用。
• CARBAMOYL-TYPE BENZOFURAN DERIVATIVES
  申请人：TANABE SEIYAKU CO., LTD.

  公开号：EP1666478A1

  公开（公告）日：2006-06-07

  The present invention provides a carbamoyl-type benzofuran derivative of the formula [1]: wherein Ring Z is a group of the formula: etc.; A is a single bond, and the like; Y is a cycloalkanediyl group, etc.; R4 and R5 are the same or different and each is an optionally substituted lower alkyl group, etc.; R1 is a halogen atom, etc.; Ring B of the formula: is an optionally substituted benzene ring; and R3 is a hydrogen atom, etc., or a pharmaceutically acceptable salt thereof, which is useful as an FXa inhibitor.

  本发明提供了一种式[1]的氨基甲酰型苯并呋喃衍生物： 其中环 Z 是式中的基团： 等；A为单键等；Y为环烷二基等；R4和R5相同或不同，且各自为任选取代的低级烷基等；R1为卤素原子等；式中的环B： 是任选取代的苯环；R3 是氢原子等，或其药学上可接受的盐，可用作 FXa 抑制剂。
• BENZOFURAN DERIVATIVE
  申请人：Mitsubishi Tanabe Pharma Corporation

  公开号：EP1489078B1

  公开（公告）日：2010-01-06